These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 30426720)

  • 41. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H
    J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
    Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
    Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
    J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas.
    Alis D; Bagcilar O; Senli YD; Yergin M; Isler C; Kocer N; Islak C; Kizilkilic O
    Jpn J Radiol; 2020 Feb; 38(2):135-143. PubMed ID: 31741126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.
    Kandemirli SG; Kocak B; Naganawa S; Ozturk K; Yip SSF; Chopra S; Rivetti L; Aldine AS; Jones K; Cayci Z; Moritani T; Sato TS
    World Neurosurg; 2021 Jul; 151():e78-e85. PubMed ID: 33819703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
    Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
    Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
    Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
    Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O
    Zhang S; Sun H; Su X; Yang X; Wang W; Wan X; Tan Q; Chen N; Yue Q; Gong Q
    J Magn Reson Imaging; 2021 Jul; 54(1):197-205. PubMed ID: 33393131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI.
    Wang B; Zhang S; Wu X; Li Y; Yan Y; Liu L; Xiang J; Li D; Yan T
    Front Oncol; 2021; 11():778627. PubMed ID: 34900728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting epidermal growth factor receptor gene amplification status in glioblastoma multiforme by quantitative enhancement and necrosis features deriving from conventional magnetic resonance imaging.
    Dong F; Zeng Q; Jiang B; Yu X; Wang W; Xu J; Yu J; Li Q; Zhang M
    Medicine (Baltimore); 2018 May; 97(21):e10833. PubMed ID: 29794775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Fully-Automatic Multiparametric Radiomics Model: Towards Reproducible and Prognostic Imaging Signature for Prediction of Overall Survival in Glioblastoma Multiforme.
    Li Q; Bai H; Chen Y; Sun Q; Liu L; Zhou S; Wang G; Liang C; Li ZC
    Sci Rep; 2017 Oct; 7(1):14331. PubMed ID: 29085044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A radiomics-based model to differentiate glioblastoma from solitary brain metastases.
    Su CQ; Chen XT; Duan SF; Zhang JX; You YP; Lu SS; Hong XN
    Clin Radiol; 2021 Aug; 76(8):629.e11-629.e18. PubMed ID: 34092362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The value of analysis of quantitative radiomics based on DTI in predicting astrocytoma IDH1 mutation].
    Wang J; Wang XM; Hu S; Xiong X; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1154-1158. PubMed ID: 32311879
    [No Abstract]   [Full Text] [Related]  

  • 54. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas.
    Wu S; Meng J; Yu Q; Li P; Fu S
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):543-550. PubMed ID: 30719536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.
    Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
    J Clin Neurosci; 2018 Jan; 47():168-173. PubMed ID: 28988652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.
    Patel SH; Batchala PP; Muttikkal TJE; Ferrante SS; Patrie JT; Fadul CE; Schiff D; Lopes MB; Jain R
    J Neurooncol; 2021 May; 152(3):523-531. PubMed ID: 33661425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
    Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
    J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glioblastomas and brain metastases differentiation following an MRI texture analysis-based radiomics approach.
    Ortiz-Ramón R; Ruiz-España S; Mollá-Olmos E; Moratal D
    Phys Med; 2020 Aug; 76():44-54. PubMed ID: 32593138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G
    Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
    Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.